Page 1 of Clinical Trials for Drug ridaforolimus MK8669, 36 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)
Last Updated: May 22, 2012
Condition(s): Breast Cancer
2
Active, not recruiting
Extension Trial of Deforolimus in Patients With Advanced Cancer (8669-038)
Last Updated: December 20, 2011
Condition(s): Advanced Cancers
3
Recruiting
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Last Updated: May 11, 2012
Condition(s): Advanced Cancer
4
Completed
Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)(COMPLETED)
Last Updated: March 13, 2012
Condition(s): Cancer; Sarcoma
5
Completed
Study of Oral AP23573 to Treat Patients With Refractory or Advanced Malignancies
Last Updated: June 2, 2010
Condition(s): Cancer
6
Completed
AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)
Last Updated: March 13, 2012
Condition(s): Endometrial Cancer
7
Completed
AP23573 in Patients With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(8669-017)(COMPLETED)
Last Updated: July 26, 2011
Condition(s): Prostate Cancer
8
Completed
Pharmacokinetics of Ridaforolimus in Chinese Participants (MK-8669-059)
Last Updated: May 4, 2012
Condition(s): Cancer, Advanced
9
Completed
Study of AP23573, an mTOR Inhibitor, in Patients With Advanced Sarcoma (8669-018)(COMPLETED)
Last Updated: July 26, 2011
Condition(s): Leiomyosarcoma; Liposarcoma; Osteosarcoma; Sarcoma, Soft Tissue; Metastases
10
Completed
Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)
Last Updated: July 7, 2011
Condition(s): Hematologic Malignancies; Leukemia; Myelodysplastic Syndromes; Myeloid Metaplasia; Lymphoma
11
Recruiting
Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids
Last Updated: April 20, 2012
Condition(s): Endometrial Cancer; Ovarian Cancer
12
Active, not recruiting
Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma(8669-007)
Last Updated: July 7, 2011
Condition(s): Endometrial Cancer
13
Completed
A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004)
Last Updated: December 17, 2010
Condition(s): Neoplasms
14
Completed
Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)
Last Updated: July 7, 2011
Condition(s): Solid Tumor
15
Completed
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
Last Updated: July 26, 2011
Condition(s): Tumors; Lymphoma; Multiple Myeloma
16
Completed
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-001)(COMPLETED)
Last Updated: July 26, 2011
Condition(s): Tumors; Lymphoma; Multiple Myeloma
17
Completed
Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)
Last Updated: June 29, 2011
Condition(s): Prostate Cancer
18
Active, not recruiting
A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)
Last Updated: May 18, 2012
Condition(s): Non-Small Cell Lung Cancer
19
Active, not recruiting
Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Eval. of the Efficacy of Ridaforolimus)(8669-011)
Last Updated: July 7, 2011
Condition(s): Metastatic Soft-Tissue Sarcomas; Metastatic Bone Sarcomas
20
Completed
A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)
Last Updated: July 7, 2011
Condition(s): Solid Tumors

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+ridaforolimus+MK8669

Page 1 of Clinical Trials for Drug ridaforolimus MK8669, 36 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About